Access to benznidazole for Chagas disease in the United States-Cautious optimism?
Drugs for neglected tropical diseases (NTD) are being excessively priced in the United States. Benznidazole, the first-line drug for Chagas disease, may become approved by the Food and Drug Administration (FDA) and manufactured by a private company in the US, thus placing it at risk of similar prici...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Public Library of Science (PLoS)
2017-09-01
|
| Σειρά: | PLoS Neglected Tropical Diseases |
| Διαθέσιμο Online: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005794&type=printable |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|